Sysmex
Top Five Articles on 360Dx Last Week: ADLM Taking on LDTs; Juno Dx Shuts Down; and More
Last week, readers were most interested in a story about the Association for Diagnostics & Laboratory Medicine's challenge to FDA's plans to regulate LDTs.
Roche Expands Partnership Agreement With Sysmex
Under the renewed terms, the companies will jointly explore more sustainable diagnostic solutions.
Sysmex Gets Approval in Japan for Retinal Dystrophy Gene Panel
The next-generation sequencing panel identifies genetic mutations that cause inherited retinal dystrophy, which results in vision problems, including blindness.
Firms including Roche and Quest have moved into the space, providing both a vote of confidence and new competition for smaller players that pioneered it.
Juntendo University, Sysmex, and ThinkCyte Collaborating on Tests, Treatments for CML
The parties will use ThinkCyte's Ghost Cytometry technology to develop better diagnostics for early detection of blood cancers and advance treatment of CML.
Dec 22, 2022
Japan Approves Sysmex Assays for Alzheimer's Disease
Nov 11, 2021